rs773398782
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM1PM2PP3_ModeratePP5
The NM_001352514.2(HLCS):c.1985G>A(p.Ser662Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00000805 in 1,614,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001352514.2 missense
Scores
Clinical Significance
Conservation
Publications
- holocarboxylase synthetase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HLCS | NM_001352514.2 | c.1985G>A | p.Ser662Asn | missense_variant | Exon 8 of 11 | ENST00000674895.3 | NP_001339443.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HLCS | ENST00000674895.3 | c.1985G>A | p.Ser662Asn | missense_variant | Exon 8 of 11 | NM_001352514.2 | ENSP00000502087.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152226Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251456 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461882Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152226Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74374 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Holocarboxylase synthetase deficiency Pathogenic:4
This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 515 of the HLCS protein (p.Ser515Asn). This variant is present in population databases (rs773398782, gnomAD 0.01%). This missense change has been observed in individuals with holocarboxylase synthetase deficiency (PMID: 36890565). ClinVar contains an entry for this variant (Variation ID: 428585). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt HLCS protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
- -
Variant summary: HLCS c.1544G>A (p.Ser515Asn) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251456 control chromosomes. c.1544G>A has been observed in multiple individuals affected with Holocarboxylase Synthetase Deficiency (examples: Ling_2023, Kim_2024). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 39194177, 36890565). ClinVar contains an entry for this variant (Variation ID: 428585). Based on the evidence outlined above, the variant was classified as pathogenic. -
the patient carry compound heterozygote mutation, one is confirmed to be pathogenic. [c.1522C>T (p.Arg508Trp)]+[ c.1544G>A(p.Ser515Asn)] -
Inborn genetic diseases Uncertain:1
The c.1544G>A (p.S515N) alteration is located in exon 9 (coding exon 6) of the HLCS gene. This alteration results from a G to A substitution at nucleotide position 1544, causing the serine (S) at amino acid position 515 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at